EP Patent

EP4662229A2 — Solid dosage forms including porcine thyroid powder and methods of making and using the same

Assigned to Genus Lifesciences Inc · Expires 2025-12-17 · 0y expired

What this patent protects

Oral solid dosage forms including porcine thyroid powder and methods of making and using the oral solid dosage forms are disclosed.

USPTO Abstract

Oral solid dosage forms including porcine thyroid powder and methods of making and using the oral solid dosage forms are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP4662229A2
Jurisdiction
EP
Classification
—
Expires
2025-12-17
Drug substance claim
No
Drug product claim
No
Assignee
Genus Lifesciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.